Nemaska Lithium Signs Supply Agreement for Spodumene

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
128
Nemaska Lithium Signs Supply Agreement for Spodumene Concentrate

QUÉBEC CITY, Quebec, May 29, 2018 (GLOBE NEWSWIRE) -- Nemaska Lithium Inc. (“Nemaska Lithium” or the “Corporation”) (TSX:NMX) (OTC:NMKEF) is pleased to announce the signing of a supply agreement (the “Agreement”) of spodumene concentrate with Hanwa Co., Ltd. (“Hanwa”) acting as agent for General Lithium Corp. (“GLC”), the latter having signed the Agreement as intervenor.  

Under this Agreement and through its wholly-owned subsidiary Nemaska Lithium Whabouchi Mine Inc., Nemaska Lithium will supply a significant quantity of spodumene concentrate on a take-or-pay basis at a market priced-based formula, at the time of delivery. The supply period will commence after the construction of the Whabouchi Mine and continue up to the full ramp-up of the electrochemical plant in Shawinigan.

“We are very pleased to conclude this commercial relationship with Hanwa, a leading, Japan-based, global trading company, and GLC, a China-based company specialized in R&D, production and sales of lithium products and one of the top class spodumene converters in China”, declared Guy Bourassa, President & Chief Executive Officer of Nemaska Lithium.

Bourassa continued, “Our business plan remains to be vertically integrated and to sell lithium hydroxide and lithium carbonate from our electrochemical plant in Shawinigan; however, given that the Whabouchi mine will be in production about a year before the electrochemical plant is ready to be commissioned, we decided to be opportunistic and sell spodumene concentrate in the interim, effectively enabling us to generate revenue by the last quarter of 2019.” 

About Nemaska Lithium

Nemaska Lithium is a developing chemical company whose activities will be vertically integrated, from spodumene mining to the commercialization of high-purity lithium hydroxide and lithium carbonate. These lithium salts are mainly destined for the fast-growing lithium-ion battery market, which is driven by the increasing demand for electric vehicles and energy storage worldwide. With its products and processes, Nemaska Lithium intends to facilitate access to green energy, for the benefit of humanity.

The Corporation will be operating the Whabouchi mine in Québec, Canada, one of the richest lithium spodumene deposits in the world, both in volume and grade. The spodumene concentrate produced at the Whabouchi mine will be processed at the Shawinigan plant using a unique membrane electrolysis process for which the Corporation holds several patents.

Nemaska Lithium is a member of the S&P/TSX SmallCap Index, S&P/TSX Global Mining Index, S&P/TSX Global Base Metals Index, S&P/TSX Equal Weight Global Base Metals Index, and the MSCI Canada Small Cap Index. For more information, visit www.nemaskalithium.com or twitter.com/Nemaska Lithium .

About Hanwa and GLC

Hanwa is a leading, Japan-based global trading company, operating in a wide range of fields. Since its inception in 1947, Hanwa has achieved steady growth in a diverse range of its businesses such as steel, metals and alloys, non-ferrous metals, food products, petroleum, chemicals, lumber, machinery and others, whilst it has been specifically focusing on the feedstock for the growing rechargeable battery industry. Based in China, GLC was founded in 2006. It is specializing in R&D, production and sales for basic lithium products and series lithium-battery new materials; its products are widely used in lithium-battery industry and centre air-conditioner industry.

Cautionary Statement on Forward-Looking Information

All statements, other than statements of historical fact, contained in this press release including, but not limited to, those relating to the sale by the Corporation and the purchase by Hanwa, on a take-or-pay basis, of a significant quantity of spodumene concentrate, constitute “forward-looking information” and “forward-looking statements” within the meaning of certain securities laws and are based on expectations and projections as of the date of this press release. Certain important assumptions by the Corporation in making forward-looking statements include, but are not limited to, (a) the conclusion of all components of the project financing and receipt of all proceeds therefrom, and (b) the construction and start of commercial production at the Whabouchi mi ne.

Forward-looking statements contained in this press release include, without limitation, those related to (i) the commencement of the supply period after the construction of the Whabouchi mine and its continuation up to the full ramp-up of the Shawinigan plant, (ii) the Corporation’s business plan to be vertically integrated and sell lithium hydroxide and lithium carbonate, (iii) the Whabouchi mine being in production a year before the commissioning of the Shawinigan plant, (iv) the Corporation generating revenue by the last quarter of 2019, and (v) generally, the above “About Nemaska Lithium” paragraph which essentially describes the Corporation’s outlook. Forward-looking statements are based on expectations, estimates and projections as of the time of this press release. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Corporation as of the time of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. These estimates and assumptions may prove to be incorrect.

Many of these uncertainties and contingencies can directly or indirectly affect, and could cause, actual results to differ materially from those expressed or implied in any forward-looking statements. There can be no assurance that the Whabouchi mine will be brought to commercial production , as results from the Corporation’s project financing endeavors and future events could differ materially what is currently anticipated by the Corporation.

By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, projections and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. Forward-looking statements are provided for the purpose of providing information about management's endeavors to complete its project financing and, more generally, its expectations and plans relating to the future. Readers are cautioned not to place undue reliance on these forward-looking statements as a number of important risk factors and future events could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates, assumptions and intentions expressed in such forward-looking statements. All of the forward-looking statements made in this press release are qualified by these cautionary statements and those made in our other filings with the securities regulators of Canada including, but not limited to, the cautionary statements made in the “Risk Factors” section of the Corporation’s Annual Information Form dated October 5, 2017 and the “Risk Exposure and Management” section of the Corporation’s quarterly Management Discussion & Analysis. The Corporation cautions that the foregoing list of factors that may affect future results is not exhaustive, and new, unforeseeable risks may arise from time to time. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law.

Further information regarding Nemaska Lithium is available in the SEDAR database (www.sedar.com) and on the Corporation's website at: www.nemaskalithium.com .

FOR FURTHER INFORMATION, PLEASE CONTACT:

Victor Cantore Investor Relations 514 831-3809 victor.cantore@nemaskalithium.com Wanda Cutler Investor Relations 416 303-6460 wanda.cutler@nemaskalithium.com
   
Fanny-Ève Tapp Media Relations B. 514 935 2777 # 204 C. 514 442 0445 fanny-eve.tapp@nemaskalithium.com  

www.nemaskalithium.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lennar Lawsuit Puts Land-Light Claims Under a Microscope

Updated Category News Views 118

Three ugly selloffs, a murky land-bank story, and a fresh securities complaint have turned Lennar into the sort of holding that makes shareholders reread every footnote. The lawsuit is not a verdict, and the allegations remain unproven, but the timeline is nasty enough that investors in NYSE:LEN should not shrug it off as ordinary housing-cycle turbulence. The Dates...

Continue Reading
V2’s FOAS Bets on Candid Ad Sales Operator Dialogue

Updated Category News Views 180

Ad sales rarely gets fixed by another ballroom panel, and V2 seems to know it. Its new Future of Ad Sales, or FOAS, forum is built around a simpler premise: put senior operators in a small room, keep vendors and conference theatrics out of the way, and let people compare the ugly real-world details of running revenue machines. Announced November 19, 2026, FOAS is an...

Continue Reading
Vail Resorts Bets on Music to Deepen Epic Pass Demand

Updated Category News Views 119

A bass drop at 11,000 feet is not merely a party trick when you run 42 mountain resorts. Vail Resorts is putting live music, après programming and destination events squarely beside skiing and riding for winter 2026-27, and the business logic is pretty plain: give people another reason to buy early, stay longer and return with friends. For investors watching MTN, this is...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 144

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 17

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
Siteimprove Turns Accessibility Checks Into Agent Spend

Updated Category News Views 153

Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...

Continue Reading
Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 71

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Colossal's Halloween Campaign Wins Top Communicator Honor

Updated Category News Views 76

A horror-themed fan competition putting money toward hospitalized children is not the usual awards-season material, which is precisely why Colossal's latest recognition lands with some weight. The Phoenix-based professional fundraiser received an Award of Excellence, the top honor at the 32nd annual Communicator Awards, for its Face of Halloween campaign in the Innovation...

Continue Reading
Makera A1S Tests the Desktop CNC Metal-Cutting Promise

Updated Category News Views 84

Aluminum chips are where desktop-machine marketing stops bluffing, and Makera is leaning right into that test with the A1S. The company opened global pre-orders on November 18 for a machine aimed squarely at the awkward middle ground: users who have outgrown entry-level hobby gear but do not have room, budget, or patience for a full industrial setup. That is a real market...

Continue Reading
Genome-Written XDP Mice Could Sharpen Drug Research

Updated Category News Views 88

Seventy-eight thousand DNA letters changed the pace of a cruel little-known disease story. NYU Langone researchers inserted a human disease-linked stretch of genetic material into mice and produced an accelerated model of X-linked dystonia-parkinsonism, or XDP. That is a serious laboratory accomplishment, not a cure announcement, and it deserves to be read with both...

Continue Reading

Top 5 Most Recently Viewed Articles

Canada Nickel Secures EDC Interest for $500 Million Financing

Updated Category News Views 137

Canada Nickel's Significant Financing Achievement Canada Nickel Company Inc. is excited to share a major milestone in its efforts to secure financing for the Crawford Nickel Sulphide Project. The company has received a Letter of Interest (LOI) from Export Development Canada (EDC), indicating its intention to offer up to US$500 million in long-term debt financing for the...

Continue Reading
BlackRock Expands Offerings with New ETF Share Class Approval

Updated Category News Views 202

BlackRock Pursues SEC Approval for ETF Share Classes BlackRock Inc (NYSE: BLK) is making headlines as it has formally applied to the U.S. Securities and Exchange Commission (SEC) for a ruling that would allow the establishment of exchange-traded fund (ETF) share classes linked to its existing mutual funds. This significant move positions BlackRock as the largest firm...

Continue Reading
Profusa Unveils Innovative AI Portal for Continuous Biochemistry Monitoring

Updated Category News Views 133

Profusa Introduces AI-Powered Insight Portal for Biomarker Monitoring Profusa, a pioneering company in digital health technology, is transforming how healthcare providers monitor patient biochemistry through an innovative AI-driven insight portal. This advanced portal will enhance continuous biomarker tracking, utilizing cutting-edge technology to provide clinical...

Continue Reading
Investigation Launch for Pliant Therapeutics Investors: What to Know

Updated Category News Views 192

Investigation of Pliant Therapeutics, Inc. Pliant Therapeutics, Inc. (NASDAQ: PLRX) is currently under scrutiny as investors seek clarity on potential securities law violations. This investigation presents an opportunity for shareholders who believe they have been misled regarding their investments. Shareholders are encouraged to come forward to ensure their rights are...

Continue Reading
Fish Window Cleaning's New Headquarters: A Step Forward in Growth

Updated Category News Views 2161

Fish Window Cleaning Unveils New Corporate Headquarters Fish Window Cleaning Services is excited to announce the grand opening of its brand-new corporate headquarters, a facility that signifies an important milestone in its growth and operational capabilities. Located at 217 Chesterfield Towne Centre, this expansive 12,500-square-foot space is intended to serve as the...

Continue Reading